FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Haas

Research Profile

Disorders

Chemicals & Drugs

Living Beings

HIV-1

Procedures

Physiology

Genotype

Anatomy

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
Xinyan Zhang; Hongyu Jiang; Gene Morse; Camlin Tierney; Mary Albrecht; Lisa M Demeter; Robin DiFrancesco; Carrie Dykes; David W Haas
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.
Daniel H Johnson; Gail Mayo; Ayumi Shintani; C Michael Stein; Edward P Acosta; Tebeb Gebretsadik; David W Haas
Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.
Heather J Ribaudo; Paul E Sax; Camlin Tierney; Ann C Collier; Eric S Daar; Margaret A Fischl; David W Haas; Katie Mollan; Gene D Morse
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Haas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Xinyan Zhang; Hongyu Jiang; Gene Morse; Camlin Tierney; Mary Albrecht; Lisa M Demeter; Robin DiFrancesco; Carrie Dykes; David W Haas
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.
Therapeutic drug monitoring 2013;35(2):209-16.
2013: Daniel H Johnson; Gail Mayo; Ayumi Shintani; C Michael Stein; Edward P Acosta; Tebeb Gebretsadik; David W Haas
Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.
British journal of clinical pharmacology 2013;75(4):997-1006.
2013: Heather J Ribaudo; Paul E Sax; Camlin Tierney; Ann C Collier; Eric S Daar; Margaret A Fischl; David W Haas; Katie Mollan; Gene D Morse
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.
The Journal of infectious diseases 2013;207(3):420-5.
2012: Emily R Holzinger; Todd Hulgan; Asha R Kallianpur; Scott Letendre; Christina M Marra; justin charles mcarthur; J Allen McCutchan; Susan Morgello; Marylyn D Ritchie; Debralee Rosario; David Samuels; Doug Selph; David M Simpson; Cinnamon S Bloss; David B Clifford; Ann C Collier; Ronald J Ellis; Donald R Franklin; Benjamin B Gelman; Igor Grant; David W Haas
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.
Journal of neurovirology 2012;18(6):511-20.
2012: Todd Hulgan; Spyros A Kalams; Deborah G Murdock; Richard B Pollard; Gregory Robbins; David Samuels; Doug Selph; Robert Shafer; Benjamin Grady; David W Haas
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.
PloS one 2012;7(8):e43803.
2012: Michael S Boger; Husamettin Erdem; David W Haas; Ginger L Milne; Valerie Mitchell; Jason D Morrow; Ayumi Shintani; Aihua Bian; Todd Hulgan
Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy.
Antiviral therapy 2012;17(3):485-93.
2012: Kelly A Birdwell; Leena Choi; James D Cowan; Josh C Denny; Ben Grady; Melissa Basford; Aihua Bian; Talat Alp Ikizler; Min Jiang; Danielle M Richardson; Marylyn D Ritchie; Melanie P Robinson; Charles Michael Stein; Gayle Vranic; Hua Xu; David W Haas
The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.
Pharmacogenetics and genomics 2012;22(1):32-42.
2011: Benjamin J Grady; David W Haas; Todd Hulgan; Spyros A Kalams; Deborah G Murdock; Richard B Pollard; Marylyn D Ritchie; Gregory K Robbins; David Samuels; Doug Selph; Robert Shafer; Jeffrey A Canter
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.
Journal of acquired immune deficiency syndromes (1999) 2011;58(4):363-70.
2011: Benjamin J Grady; Eric S Torstenson; Paul J McLaren; Paul I W de Bakker; David W Haas; Gregory K Robbins; Roy M Gulick; Richard Haubrich; Heather Ribaudo; Marylyn Ritchie
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in art-naïve ACTG clinical trials participants.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2011;():253-64.
2010: Heather J Ribaudo; Huan Liu; Matthias Schwab; Elke Schaeffeler; Michel Eichelbaum; Alison A Motsinger-Reif; Marylyn Ritchie; Ulrich M Zanger; Edward P Acosta; Gene D Morse; Roy M Gulick; Gregory K Robbins; David Clifford; David W Haas
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.
The Journal of infectious diseases 2010;202(5):717-22.
2010: Jeffrey A Canter; Gregory K Robbins; Doug Selph; David B Clifford; Asha R Kallianpur; Robert Shafer; Shawn Levy; Deborah G Murdock; Marylyn Ritchie; David W Haas; Todd Hulgan
African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy.
The Journal of infectious diseases 2010;201(11):1703-7.
2010: James P Smith; Stephen Weller; Benjamin Johnson; Janet Nicotera; James M Luther; David W Haas
Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function.
Antimicrobial agents and chemotherapy 2010;54(3):1146-51.
2010: Shanmugalakshmi Sadagopal; Shelly L Lorey; Louise Barnett; Deborah Sutherland; Rebecca Basham; Husamettin Erdem; Spyros A Kalams; David W Haas
Enhanced PD-1 expression by T cells in cerebrospinal fluid does not reflect functional exhaustion during chronic human immunodeficiency virus type 1 infection.
Journal of virology 2010;84(1):131-40.
2009: Michael S Boger; Ayumi Shintani; Leigh Anne Redhage; Valerie Mitchell; David W Haas; Jason D Morrow; Todd Hulgan
Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.
Journal of acquired immune deficiency syndromes (1999) 2009;52(4):480-7.
2009: Todd Hulgan; John P Donahue; Laura Smeaton; Minya Pu; Hongying Wang; Michael M Lederman; Kimberly Smith; Hernan Valdez; Christopher D Pilcher; David W Haas
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitors.
European journal of clinical pharmacology 2009;65(11):1081-8.
2009: Rebecca J Basham; Danielle M Richardson; Cara B Sutcliffe; David W Haas
Effect of HIV-1 infection on human DNA yield from saliva.
HIV clinical trials 2009;10(4):282-5.
2009: David W Haas; Susan L Koletar; Laura Laughlin; Michelle A Kendall; Carol Suckow; John G Gerber; Andrew R Zolopa; Richard Bertz; Michael J Child; Lara Hosey; Beverly Alston-Smith; Edward P Acosta
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
Journal of acquired immune deficiency syndromes (1999) 2009;50(3):290-3.
2008: Shanmugalakshmi Sadagopal; Shelly L Lorey; Louise Barnett; Rebecca Basham; Laurie Lebo; Husamettin Erdem; Kirsten Haman; Malcolm Avison; Kevin Waddell; David W Haas; Spyros A Kalams
Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naive HIV-positive subjects.
Journal of virology 2008;82(21):10418-28.
2008: John W Baddley; John R Perfect; Robert A Oster; Robert A Larsen; George A Pankey; H Henderson; David W Haas; Carol A Kauffman; R Patel; Aimee K Zaas; Peter G Pappas
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(10):937-43.
2008: T Pepper; P Joseph; C Mwenya; G-S McKee; A Haushalter; A Carter; J Warkentin; David W Haas; Timothy R Sterling
Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2008;12(4):397-403.
2008: Todd Hulgan; Pablo Tebas; Jeffrey A Canter; Kathleen Mulligan; David W Haas; Michael Dubé; Steven Grinspoon; Gregory Robbins; Alison A Motsinger; Asha R Kallianpur
Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy.
The Journal of infectious diseases 2008;197(6):858-66.
2008: Jeffrey A Canter; David W Haas; Asha R Kallianpur; Marylyn Ritchie; Gregory Robbins; Robert W Shafer; David B Clifford; D G Murdock; Todd Hulgan
The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy.
The pharmacogenomics journal 2008;8(1):71-7.
2007: Edward P Acosta; Michelle A Kendall; John G Gerber; Beverly Alston-Smith; Susan L Koletar; Andrew R Zolopa; Sangeeta Agarwala; Michael Child; Richard Bertz; Lara Hosey; David W Haas
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
Antimicrobial agents and chemotherapy 2007;51(9):3104-10.
2007: Alison A Motsinger; David W Haas; Todd Hulgan; Marylyn Ritchie
Human genomic association studies: a primer for the infectious diseases specialist.
The Journal of infectious diseases 2007;195(12):1737-44.
2007: Kyra Oswald-Richter; Stacy M Grill; Mindy Leelawong; Michelle Tseng; Spyros A Kalams; Todd Hulgan; David W Haas; Derya Unutmaz
Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.
PLoS pathogens 2007;3(4):e58.
2007: Sharon A Riddler; Hongyu Jiang; Allan Tenorio; Hairong Huang; Daniel R Kuritzkes; Edward P Acosta; Alan Landay; Barbara Bastow; David W Haas; Karen T Tashima; Mamta K Jain; Steven G Deeks; John A Bartlett
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115.
Antiviral therapy 2007;12(4):531-41.
2006: Todd Hulgan; David W Haas
Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity.
The Journal of infectious diseases 2006;194(11):1471-4.
2006: Alison A Motsinger; Marylyn Ritchie; Robert W Shafer; Gregory Robbins; Gene D Morse; Line Labbe; Grant R Wilkinson; David B Clifford; Richard T D'Aquila; Victoria A Johnson; Richard B Pollard; Thomas C Merigan; Martin S Hirsch; John P Donahue; Richard B Kim; David W Haas
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.
Pharmacogenetics and genomics 2006;16(11):837-45.
2006: David W Haas; Daniel E Geraghty; Janet Andersen; Jessica Mar; Alison A Motsinger; Richard T D'Aquila; Derya Unutmaz; Constance A Benson; Marylyn Ritchie; Alan Landay
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study.
The Journal of infectious diseases 2006;194(8):1098-107.
2006: David W Haas; John A Bartlett; Janet W Andersen; Ian Sanne; Grant R Wilkinson; John Hinkle; Franck Rousseau; Christiana D Ingram; Audrey Shaw; Michael M Lederman; Richard B Kim
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(6):783-6.
2006: Marylyn Ritchie; David W Haas; Alison A Motsinger; John P Donahue; Huso Erdem; Stephen Raffanti; Peter Rebeiro; Alfred L George; Richard B Kim; Jonathan L Haines; Timothy R Sterling
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(6):779-82.
2006: Todd Hulgan; Michael Hughes; Xin Sun; Laura M Smeaton; Erin S Terry; Gregory Robbins; Robert W Shafer; David B Clifford; Grace A McComsey; Jeffrey A Canter; Jason D Morrow; David W Haas
Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study.
Journal of acquired immune deficiency syndromes (1999) 2006;42(4):450-4.
2006: Asha R Kallianpur; Todd Hulgan; Jeffrey A Canter; Marylyn Ritchie; Jonathan L Haines; Gregory Robbins; Robert W Shafer; David B Clifford; David W Haas
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.
AIDS (London, England) 2006;20(11):1503-13.
2006: Timothy R Sterling; David W Haas
Transmission of Mycobacterium tuberculosis from health care workers.
The New England journal of medicine 2006;355(2):118-21.
2006: David W Haas
Can responses to antiretroviral therapy be improved by therapeutic drug monitoring?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(8):1197-9.
2006: Heather J Ribaudo; David W Haas; Camlin Tierney; Richard B Kim; Grant R Wilkinson; Roy M Gulick; David B Clifford; Catia Marzolini; Courtney V Fletcher; Karen T Tashima; Daniel R Kuritzkes; Edward P Acosta
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(3):401-7.
2005: David W Haas; Laura M Smeaton; Robert W Shafer; Gregory Robbins; Gene D Morse; Line Labbe; Grant R Wilkinson; David B Clifford; Richard T D'Aquila; Victor De Gruttola; Richard B Pollard; Thomas C Merigan; Martin S Hirsch; Alfred L George; John P Donahue; Richard B Kim
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.
The Journal of infectious diseases 2005;192(11):1931-42.
2005: Todd Hulgan; David W Haas; Jonathan L Haines; Marylyn Ritchie; Gregory Robbins; Robert W Shafer; David B Clifford; Asha R Kallianpur; Marshall Summar; Jeffrey A Canter
Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study.
AIDS (London, England) 2005;19(13):1341-9.
2005: David W Haas
Will pharmacogenomic discoveries improve HIV therapeutics?
Topics in HIV medicine : a publication of the International AIDS Society, USA 2005;13(3):90-5.
2004: David W Haas; Heather J Ribaudo; Richard B Kim; Camlin Tierney; Grant R Wilkinson; Roy M Gulick; David B Clifford; Todd Hulgan; Catia Marzolini; Edward P Acosta
Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.
AIDS (London, England) 2004;18(18):2391-400.
2004: Constance A Benson; Charles van der Horst; Anthony Lamarca; David W Haas; Cheryl K McDonald; Corklin R Steinhart; John Rublein; Joseph B Quinn; Elsa Mondou; Franck Rousseau
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV.
AIDS (London, England) 2004;18(17):2269-76.
2004: Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.
PLoS biology 2004;2(7):E198.
2004: Donna Mildvan; Ronald J Bosch; Ryung S. Kim; John Spritzler; David W Haas; Daniel R Kuritzkes; Jonathan Kagan; Mostafa Nokta; Victor DeGruttola; Melanie Moreno; Alan Landay
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response.
The Journal of infectious diseases 2004;189(10):1811-20.
2004: David W Haas
Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapy.
Journal of neurovirology 2004;10 Suppl 1():33-7.
2003: Todd Hulgan; Jason Morrow; Richard T D'Aquila; Stephen Raffanti; Michael Morgan; Peter Rebeiro; David W Haas
Oxidant stress is increased during treatment of human immunodeficiency virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(12):1711-7.
2003: David W Haas; B W Johnson; Paul Spearman; Stephen Raffanti; Janet Nicotera; D Schmidt; Todd Hulgan; R Shepard; Susan A Fiscus
Two phases of HIV RNA decay in CSF during initial days of multidrug therapy.
Neurology 2003;61(10):1391-6.
2003: David W Haas; Hulin Wu; Haihong Li; Ronald J Bosch; Michael M Lederman; Daniel R Kuritzkes; Alan Landay; Elizabeth Connick; Constance Benson; Grant R Wilkinson; Harold Kessler; Richard B Kim
MDR1 gene polymorphisms and phase 1 viral decay during HIV-1 infection: an adult AIDS Clinical Trials Group study.
Journal of acquired immune deficiency syndromes (1999) 2003;34(3):295-8.
2003: Todd Hulgan; John P Donahue; Charlene Hawkins; Derya Unutmaz; Richard T D'Aquila; Stephen Raffanti; Fred Nicotera; Peter Rebeiro; Husamettin Erdem; Melissa Rueff; David W Haas
Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;34(2):119-26.
2003: David W Haas; Grant R Wilkinson; Daniel R Kuritzkes; Douglas D Richman; Janet Nicotera; Laura F Mahon; Cara Sutcliffe; Sue Siminski; Janet Andersen; Kristine Coughlin; Ellen Wright Clayton; Jonathan L Haines; Ann Marshak; Michael Saag; Jody Lawrence; Jeffrey Gustavson; Jo Anne Bennett; Rolf Christensen; Margaret A Matula; Alastair J J Wood
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128.
HIV clinical trials 2003;4(5):287-300.
2003: John Spritzler; Donna Mildvan; Aleksandra Russo; Deshratn Asthana; Daniella Livnat; Barbara Schock; Jonathan Kagan; Alan Landay; David W Haas
Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(4):551-8.
2003: Hua-zhong Lu; Xin-hua Weng; Bai Zhu; Haijing Li; You-Kuan Yin; Yong-Xin Zhang; David W Haas; Yi-Wei Tang
Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis.
Journal of clinical microbiology 2003;41(7):3051-5.
2003: David W Haas; Benjamin Johnson; Janet Nicotera; Vicki L Bailey; Victoria L Harris; Farideh B Bowles; Stephen Raffanti; Jennifer Schranz; Tyler S Finn; Alfred J Saah; Julie Stone
Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma.
Antimicrobial agents and chemotherapy 2003;47(7):2131-7.
2003: David W Haas; Carlos Zala; Shannon Schrader; Peter J Piliero; Hans Jaeger; Danilo Nunes; Alexandra Thiry; Steven Schnittman; Michael Sension
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.
AIDS (London, England) 2003;17(9):1339-49.
2003: Alfred J Saah; David W Haas; Mark J DiNubile; Joshua Chen; Daniel J Holder; Rand R Rhodes; Malathi Shivaprakash; Kalpana K Bakshi; Robert M Danovich; Donald J Graham; Jon H Condra
Treatment with indinavir, efavirenz, and adefovir after failure of nelfinavir therapy.
The Journal of infectious diseases 2003;187(7):1157-62.
2003: John P Donahue; David Dowdy; Krishna K Ratnam; Todd Hulgan; James Price; Derya Unutmaz; Janet Nicotera; Stephen Raffanti; Mark Becker; David W Haas
Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy.
Clinical pharmacology and therapeutics 2003;73(1):78-86.
2002: Alison A Motsinger; David W Haas; Aleksandar Stanic; Luc Van Kaer; Sebastian JOYCE; Derya Unutmaz
CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection.
The Journal of experimental medicine 2002;195(7):869-79.
2002: Yi-Wei Tang; Haijing Li; Jane P Griffin; David W Haas; Erika M C D'Agata
Rapidly increasing prevalence of penicillin-resistant Streptococcus pneumoniae in middle Tennessee: a 10-year clinical and molecular analysis.
Journal of clinical microbiology 2002;40(2):395-9.
2001: Douglas McMahon; Michael M Lederman; David W Haas; R Haubrich; J Stanford; E Cooney; J Horton; D Kelleher; L Ross; Amy Cutrell; D Lee; William Spreen; John W Mellors
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults.
Antiviral therapy 2001;6(2):105-14.
2001: Paul Spearman; Susan A Fiscus; R M Smith; R Shepard; Benjamin Johnson; Janet Nicotera; Victoria L Harris; LA Clough; J McKinsey; David W Haas
Comparison of Roche MONITOR and Organon Teknika NucliSens assays to quantify human immunodeficiency virus type 1 RNA in cerebrospinal fluid.
Journal of clinical microbiology 2001;39(4):1612-4.
2001: David W Haas; W J Fessel; R A Delapenha; H Kessler; D Seekins; Mark H Kaplan; N M Ruiz; L M Ploughman; D F Labriola; D J Manion
Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial.
The Journal of infectious diseases 2001;183(3):392-400.
2000: Michael M Lederman; R McKinnis; D Kelleher; Amy Cutrell; J Mellors; M Neisler; E Cooney; David W Haas; R Haubrich; J Stanford; J Horton; Alan Landay; William Spreen
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.
AIDS (London, England) 2000;14(17):2635-42.
2000: Y W Tang; J T Huong; R M Lloyd; Paul Spearman; David W Haas
Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma.
Journal of clinical microbiology 2000;38(12):4637-9.
2000: Jörn-Hendrik Weitkamp; Yi-Wei Tang; David W Haas; N K Midha; James Crowe
Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1183-7.
2000: David W Haas; LA Clough; B W Johnson; Victoria L Harris; Paul Spearman; Grant R Wilkinson; Courtney V Fletcher; Susan A Fiscus; Stephen Raffanti; R Donlon; J McKinsey; Janet Nicotera; D Schmidt; R E Shoup; R E Kates; R M Lloyd; B Larder
Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma.
AIDS research and human retroviruses 2000;16(15):1491-502.
2000: David W Haas; J Stone; LA Clough; Benjamin Johnson; Paul Spearman; Victoria L Harris; Janet Nicotera; R H Johnson; Stephen Raffanti; L Zhong; P Bergqwist; S Chamberlin; V Hoagland; WD Ju
Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection.
Clinical pharmacology and therapeutics 2000;68(4):367-74.
2000: David W Haas; Eduardo G Arathoon; M A Thompson; R de Jesus Pedro; Joel E Gallant; David E Uip; Jeff Currier; L M Noriega; DS Lewi; P Uribe; L Benetucci; Pedro Cahn; D Paar; A C White; A C Collier; C H Ramirez-Ronda; C Harvey; M O Chung; D Mehrotra; Jeffrey A Chodakewitz; B Y Nguyen
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine.
AIDS (London, England) 2000;14(13):1973-8.
2000: J M Luther; David L Lakey; Richard Larson; Asha R Kallianpur; Erika M C D'Agata; John B Cousar; David W Haas
Utility of bone marrow biopsy for rapid diagnosis of febrile illnesses in patients with human immunodeficiency virus infection.
Southern medical journal 2000;93(7):692-7.
2000: Seth W Wright; Keith Wrenn; MaryLou Haynes; David W Haas
Prevalence and risk factors for multidrug resistant uropathogens in ED patients.
The American journal of emergency medicine 2000;18(2):143-6.
2000: David W Haas; J Lavelle; J P Nadler; S B Greenberg; P Frame; N Mustafa; M St Clair; R McKinnis; L Dix; M Elkins; James F Rooney
A randomized trial of interferon alpha therapy for HIV type 1 infection.
AIDS research and human retroviruses 2000;16(3):183-90.
2000: K Green; Gerald Schulman; David W Haas; William Schaffner; Erika M C D'Agata
Vancomycin prescribing practices in hospitalized chronic hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;35(1):64-8.
1999: LA Clough; Erika M C D'Agata; Stephen Raffanti; David W Haas
Factors that predict incomplete virological response to protease inhibitor-based antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(1):75-81; discussion 82-4.
1998: David W Haas; S Milton; Barry N Kreiswirth; V L Brinsko; Pablo Bifani; William Schaffner
Nosocomial transmission of a drug-sensitive W-variant Mycobacterium tuberculosis strain among patients with acquired immunodeficiency syndrome in Tennessee.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1998;19(9):635-9.
1998: David W Haas; Michael M Lederman; LA Clough; Robert Wallis; D Chernoff; S L Crampton
Proinflammatory cytokine and human immunodeficiency virus RNA levels during early Mycobacterium avium complex bacteremia in advanced AIDS.
The Journal of infectious diseases 1998;177(6):1746-9.
1996: David W Haas; M P McAndrew
Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment.
The American journal of medicine 1996;101(5):550-61.
1996: David W Haas; T Bonczar
Effect of replacing cefotaxime with ceftizoxime in a hospital where penicillin-resistant pneumococcal disease is prevalent.
The Journal of antimicrobial chemotherapy 1996;38(2):293-9.
1995: David W Haas; S Raffanti; F Chytil; D Lakey; S Alls
Impaired hepatic protein synthesis in AIDS patients with low vitamin A levels.
The Journal of infectious diseases 1995;172(4):1167-9.
1995: David W Haas; Charles W Stratton; J P Griffin; L Weeks; S C Alls
Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(3):671-6.
1995: S J Antony; David W Haas
Tuberculous pericarditis in an HIV-infected patient.
Scandinavian journal of infectious diseases 1995;27(4):411-3.
1994: Kathleen M Neuzil; E Wang; David W Haas; Martin Blaser
Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies.
Journal of clinical microbiology 1994;32(7):1718-20.
1994: David W Haas; R M Des Prez
Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments.
The American journal of medicine 1994;96(5):439-50.
1994: W B Harley; M Lomis; David W Haas
Marked polymorphonuclear pleocytosis due to blastomycotic meningitis: case report and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(5):816-8.
1993: P R Graves; David W Haas; C H Hagedorn; A A DePaoli-Roach; Peter J Roach
Molecular cloning, expression, and characterization of a 49-kilodalton casein kinase I isoform from rat testis.
The Journal of biological chemistry 1993;268(9):6394-401.
1993: X Bu; David W Haas; C H Hagedorn
Novel phosphorylation sites of eukaryotic initiation factor-4F and evidence that phosphorylation stabilizes interactions of the p25 and p220 subunits.
The Journal of biological chemistry 1993;268(7):4975-8.
1992: Lucy C Robinson; E J Hubbard; P R Graves; A A DePaoli-Roach; Peter J Roach; C Kung; David W Haas; C H Hagedorn; Mark G Goebl; M R Culbertson
Yeast casein kinase I homologues: an essential gene pair.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):28-32.
1992: David W Haas; C H Hagedorn
Protein kinase C phosphorylates both serine and threonine residues of the mRNA cap binding protein eIF-4E.
Second messengers and phosphoproteins 1992;14(1-2):55-63.
1992: David W Haas; V L Shepherd; C H Hagedorn
Lipopolysaccharide stimulates phosphorylation of eukaryotic initiation factor-4F in macrophages and tumor necrosis factor participates in this event.
Second messengers and phosphoproteins 1992;14(3):163-71.
1991: David W Haas; C H Hagedorn
Casein kinase I phosphorylates the 25-kDa mRNA cap-binding protein.
Archives of biochemistry and biophysics 1991;284(1):84-9.
1990: R M Sneeringer; David W Haas
Cutaneous alternaria infection in a patient on chronic corticosteroids.
Journal of the Tennessee Medical Association 1990;83(1):15-7.
1989: David W Haas; D W Gregory
Fever and abdominal pain in a southeast Asian man.
Southern medical journal 1989;82(1):47-50.
1988: E L McMullin; David W Haas; R D Abramson; R E Thach; William C Merrick; C H Hagedorn
Identification of a protein kinase activity in rabbit reticulocytes that phosphorylates the mRNA cap binding protein.
Biochemical and biophysical research communications 1988;153(1):340-6.